Immunocore Holdings plc (IMCR)
USD 27.56
(-5.1%)
USD 27.56
(-5.1%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -358.59 Million USD | -36.23% |
| 2022 | -263.23 Million GBP | -51.24% |
| 2021 | -174.05 Million GBP | -164.4% |
| 2020 | -65.82 Million GBP | -352.15% |
| 2019 | -14.55 Million GBP | 86.2% |
| 2018 | -105.5 Million GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -32.03 Million USD | 91.1% |
| 2024 Q1 | -360.04 Million USD | -0.41% |
| 2023 Q3 | -357.02 Million USD | -2.47% |
| 2023 Q2 | -348.43 Million USD | -29.37% |
| 2023 FY | -358.59 Million USD | -36.23% |
| 2023 Q1 | -269.32 Million USD | -2.31% |
| 2023 Q4 | -358.59 Million USD | -0.44% |
| 2022 Q3 | -273.1 Million GBP | -94.56% |
| 2022 Q2 | -140.37 Million GBP | 0.55% |
| 2022 FY | -263.23 Million GBP | -51.24% |
| 2022 Q1 | -141.14 Million GBP | 18.9% |
| 2022 Q4 | -263.23 Million GBP | 3.61% |
| 2021 Q1 | -249.3 Million GBP | -278.71% |
| 2021 FY | -174.05 Million GBP | -164.4% |
| 2021 Q4 | -174.05 Million GBP | 9.29% |
| 2021 Q3 | -191.87 Million GBP | 11.03% |
| 2021 Q2 | -215.66 Million GBP | 13.49% |
| 2020 Q3 | -22.72 Million GBP | 0.0% |
| 2020 FY | -65.82 Million GBP | -352.15% |
| 2020 Q4 | -65.82 Million GBP | -189.64% |
| 2019 FY | -14.55 Million GBP | 86.2% |
| 2019 Q4 | -14.55 Million GBP | 0.0% |
| 2018 FY | -105.5 Million GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -541.033% |
| Alkermes plc | -166.73 Million USD | -115.063% |
| Agenus Inc. | 274.13 Million USD | 230.809% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 119.177% |
| Aptorum Group Limited | 1.35 Million USD | 26524.602% |
| Ardelyx, Inc. | 34.51 Million USD | 1139.041% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 8478.364% |
| Bicycle Therapeutics plc | -481.46 Million USD | 25.521% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 1091.605% |
| ChromaDex Corporation | -24.04 Million USD | -1391.159% |
| Chimerix, Inc. | -25.51 Million USD | -1305.314% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 5246.241% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1414.525% |
| CRISPR Therapeutics AG | -150.84 Million USD | -137.723% |
| Precision BioSciences, Inc. | -85.41 Million USD | -319.85% |
| Dyadic International, Inc. | -6.37 Million USD | -5522.271% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -2150.637% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4778.33% |
| Lantern Pharma Inc. | -21.7 Million USD | -1552.257% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -224.411% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -4097.432% |
| Incyte Corporation | -3.17 Billion USD | 88.706% |
| IO Biotech, Inc. | -140.69 Million USD | -154.866% |
| Jaguar Health, Inc. | 29.39 Million USD | 1320.081% |
| Novavax, Inc. | -298.29 Million USD | -20.215% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 6819.018% |
| Opthea Limited | 28.15 Million USD | 1373.532% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -2035.887% |
| ContextLogic Inc. | -232 Million USD | -54.566% |
| MiMedx Group, Inc. | -33.9 Million USD | -957.768% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3617.352% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -15376.47% |
| NextCure, Inc. | -6.47 Million USD | -5436.421% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -610.073% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -5521.477% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 3048.172% |
| Vaxcyte, Inc. | -368.22 Million USD | 2.616% |
| PDS Biotechnology Corporation | -32.7 Million USD | -996.319% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 2175.437% |
| Pharming Group N.V. | 109.8 Million USD | 426.576% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1961.359% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -104.642% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1836.268% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1836.268% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4950.62% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -6019.352% |
| Acelyrin, Inc. | -216.9 Million USD | -65.325% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -6291.746% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -20700.116% |
| Summit Therapeutics Inc. | 34.67 Million USD | 1134.187% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -5171.116% |
| Senti Biosciences, Inc. | 1.74 Million USD | 20708.851% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -94.247% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -362.995% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5815.44% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 359524.27% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 57200.955% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -206.37% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -113.153% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 423.436% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -4620.827% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -177.734% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 5301.086% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -47.957% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1947.963% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -13.227% |
| MEI Pharma, Inc. | -3.7 Million USD | -9578.65% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2966.23% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 321.707% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1390.231% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4778.33% |
| Precigen, Inc. | -481 Thousand USD | -74451.767% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2646.652% |
| AlloVir, Inc. | -62.69 Million USD | -471.993% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -544.791% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 681.51% |
| ImmuCell Corporation | 10.99 Million USD | 3362.745% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -132.633% |
| Onconetix, Inc. | 5.33 Million USD | 6826.029% |
| PureTech Health plc | -167.19 Million USD | -114.474% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -1077.262% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1775.688% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -7204.828% |
| Seer, Inc. | -4.24 Million USD | -8357.406% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1391.842% |
| Innoviva, Inc. | 255.56 Million USD | 240.315% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -541.905% |
| ESSA Pharma Inc. | -33.62 Million USD | -966.559% |
| GlycoMimetics, Inc. | -40.98 Million USD | -774.952% |
| GT Biopharma, Inc. | -1.02 Million USD | -35021.841% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -429.032% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 685.393% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -167.45% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2488.005% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -1142.013% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -475905.522% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -1061.927% |
| Aptose Biosciences Inc. | -8.19 Million USD | -4275.842% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -11360.273% |
| Soligenix, Inc. | -4.95 Million USD | -7141.987% |
| Century Therapeutics, Inc. | 847 Thousand USD | 42436.954% |
| Kura Oncology, Inc. | -20.11 Million USD | -1682.454% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -776.201% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -4169.993% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 19784.634% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -11116.578% |
| Autolus Therapeutics plc | -186.59 Million USD | -92.174% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -627.312% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -30.022% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1146.44% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 318.165% |
| GRI Bio, Inc. | -1.79 Million USD | -19888.517% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3891.898% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -978.251% |
| IGM Biosciences, Inc. | -72.6 Million USD | -393.89% |
| INmune Bio, Inc. | -25.41 Million USD | -1311.176% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 337.557% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -607.858% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2106.818% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -12329.92% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 1043.296% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -770.691% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1224.648% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 194.878% |
| Verastem, Inc. | -37.27 Million USD | -861.945% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3852.32% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -591.439% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -2269.303% |
| Histogen Inc. | -7.48 Million USD | -4689.555% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1559.633% |
| Surrozen, Inc. | -32.66 Million USD | -997.826% |
| Organovo Holdings, Inc. | -1.5 Million USD | -23695.222% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8430.868% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1991.298% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 13807.722% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 8728.345% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -4178.578% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -725.455% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2360.022% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -13.196% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -49562.632% |
| Apollomics, Inc. | -27.39 Million USD | -1208.976% |
| Amarin Corporation plc | -191.04 Million USD | -87.706% |
| Mesoblast Limited | 55.96 Million USD | 740.77% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2358.818% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1317.816% |
| Synaptogenix, Inc. | -28.66 Million USD | -1151.135% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -38211.325% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 835.849% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -41495.937% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4835.178% |
| Exelixis, Inc. | -73.05 Million USD | -390.888% |
| Better Therapeutics, Inc. | -860 Thousand USD | -41596.977% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1393.333% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -48.565% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 48817.642% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4721.02% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 28696.013% |
| Gritstone bio, Inc. | 39.49 Million USD | 1008.063% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -326.385% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -13523.667% |
| Avid Bioservices, Inc. | 169.72 Million USD | 311.276% |
| Insmed Incorporated | 721.62 Million USD | 149.693% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3822.699% |
| MediWound Ltd. | -5.32 Million USD | -6637.956% |
| OmniAb, Inc. | 9.2 Million USD | 3996.49% |
| Alector, Inc. | -35.63 Million USD | -906.241% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 517.11% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -7176.664% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2808.618% |
| Zai Lab Limited | -775 Million USD | 53.73% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 205.297% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1565.942% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -334.765% |
| Immunic, Inc. | -45.34 Million USD | -690.9% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -85.593% |
| Veracyte, Inc. | -203.82 Million USD | -75.933% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 156.18% |
| FibroGen, Inc. | 56.76 Million USD | 731.694% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4126.884% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -12584.245% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -17220.47% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 107.812% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -10633.134% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -116.067% |
| TG Therapeutics, Inc. | 17.86 Million USD | 2107.58% |
| Galecto, Inc. | -21.21 Million USD | -1590.206% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1407.648% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 122.849% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1365.324% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -3016.312% |
| XBiotech Inc. | -200.02 Million USD | -79.276% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -326.385% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 8019.479% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -916.913% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -364.392% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 6401.072% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -110.424% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -288.198% |
| Vaxxinity, Inc. | 10.13 Million USD | 3639.222% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 148.704% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -3230.321% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -443.687% |
| NexImmune, Inc. | -3.13 Million USD | -11343.358% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -10285.982% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -2272.995% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1223.225% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3895.008% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -287753.903% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -783.846% |
| Ainos, Inc. | 4.07 Million USD | 8893.534% |
| Pluri Inc. | 22.82 Million USD | 1670.783% |
| Prothena Corporation plc | -608.34 Million USD | 41.054% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -201.959% |
| Celularity Inc. | 65.19 Million USD | 650.075% |
| Rallybio Corporation | -24.1 Million USD | -1387.818% |
| Cue Biopharma, Inc. | -33.81 Million USD | -960.333% |
| MeiraGTx Holdings plc | -40.3 Million USD | -789.767% |
| Omeros Corporation | 331.17 Million USD | 208.279% |
| Humacyte, Inc. | -22.48 Million USD | -1494.743% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1359.182% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -1060.461% |
| Blueprint Medicines Corporation | 702.83 Million USD | 151.021% |
| CalciMedica, Inc. | -5.53 Million USD | -6384.521% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -90.519% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -3410.809% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -795.657% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -978.381% |
| Pulmatrix, Inc. | -10.41 Million USD | -3342.392% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -5899.565% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -840.155% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -221.892% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -498.215% |
| Cytokinetics, Incorporated | 642.37 Million USD | 155.823% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -6058.235% |
| Nutriband Inc. | -251.65 Thousand USD | -142393.155% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -951.01% |
| Vor Biopharma Inc. | 4.3 Million USD | 8439.395% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 94.059% |
| Evogene Ltd. | -19.63 Million USD | -1726.393% |
| ProKidney Corp. | -56.23 Million USD | -537.659% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -636.756% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3782.069% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 126.292% |
| CorMedix Inc. | -43.05 Million USD | -732.922% |
| BioLineRx Ltd. | 7.33 Million USD | 4988.141% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1205.64% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 877.069% |
| Atai Life Sciences N.V. | -28.55 Million USD | -1155.669% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 16176.635% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1471.678% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 2121.957% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -377.654% |
| MediciNova, Inc. | -50.78 Million USD | -606.123% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -355.04% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1594005.357% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5457.366% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -79.458% |
| Biomea Fusion, Inc. | -166.57 Million USD | -115.281% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -100.36% |
| Mereo BioPharma Group plc | -51.46 Million USD | -596.718% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -278.088% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -22.071% |
| Absci Corporation | -72.59 Million USD | -393.945% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7953.57% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -52.96% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -280.629% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -274.722% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -817.754% |
| Allakos Inc. | -24.97 Million USD | -1335.812% |
| Imunon, Inc. | -4.21 Million USD | -8409.886% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -2332.465% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -164.84% |
| BioAtla, Inc. | -109.01 Million USD | -228.952% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 48817.642% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -38088.924% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 3096.774% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1591.242% |
| XOMA Corporation | -29 Million USD | -1136.531% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -2065.423% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3877.307% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4713.988% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -187.713% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -72.265% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -338.492% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -286.57% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -41636.578% |
| Akari Therapeutics, Plc | -3.84 Million USD | -9226.242% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22196.014% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 125.969% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30081.25% |
| UroGen Pharma Ltd. | 4.39 Million USD | 8266.568% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 415.995% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 498410.219% |
| Orgenesis Inc. | 21.78 Million USD | 1746.135% |
| Entera Bio Ltd. | -10.62 Million USD | -3273.732% |
| GH Research PLC | -78.07 Million USD | -359.283% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1508.911% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1245.114% |
| Xencor, Inc. | 29.64 Million USD | 1309.668% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -18104.478% |
| Replimune Group, Inc. | 1.41 Million USD | 25496.176% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -146319.88% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -183.66% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -30081.25% |
| Portage Biotech Inc. | -4.98 Million USD | -7099.237% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1594005.357% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -442.322% |
| OncoCyte Corporation | -6.56 Million USD | -5363.873% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 40058.637% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -7771.425% |
| Purple Biotech Ltd. | -14.13 Million USD | -2436.384% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1409.488% |
| scPharmaceuticals Inc. | -6.54 Million USD | -5378.9% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -2048.277% |
| HilleVax, Inc. | -165.48 Million USD | -116.693% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -14028.999% |
| Tharimmune, Inc. | -10.93 Million USD | -3179.218% |
| Genprex, Inc. | -6.73 Million USD | -5222.258% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 2.769% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -305.374% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -25495.575% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -10710.969% |
| OKYO Pharma Limited | -826.84 Thousand USD | -43268.793% |
| Savara Inc. | 153 Thousand USD | 234475.163% |
| Curis, Inc. | -23.88 Million USD | -1401.21% |
| Daré Bioscience, Inc. | -5.15 Million USD | -6852.311% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -46109.852% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -5676.321% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 30361.097% |
| BeiGene, Ltd. | -2.25 Billion USD | 84.084% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 3006.301% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 41.041% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -93.223% |
| Erasca, Inc. | -37.21 Million USD | -863.548% |
| bluebird bio, Inc. | 108.57 Million USD | 430.285% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -27743.462% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 194.679% |
| DBV Technologies S.A. | -126.98 Million USD | -182.389% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -27743.462% |
| Moderna, Inc. | -2.9 Billion USD | 87.664% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -3364.007% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -3199.54% |
| Molecular Templates, Inc. | 707 Thousand USD | 50820.509% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -1043.075% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 203.458% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -336.979% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -290.923% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -1011.161% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -943.152% |
| MacroGenics, Inc. | -66.98 Million USD | -435.335% |
| RenovoRx, Inc. | -1.17 Million USD | -30470.673% |
| Adicet Bio, Inc. | -138.78 Million USD | -158.377% |
| Prime Medicine, Inc. | -27.94 Million USD | -1183.397% |
| Aditxt, Inc. | 18.12 Million USD | 2078.899% |
| Adagene Inc. | -87.62 Million USD | -309.226% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8508.815% |
| Quantum-Si incorporated | -118.55 Million USD | -202.465% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 1095.956% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4697.765% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -639.232% |
| SciSparc Ltd. | -2.06 Million USD | -17265.327% |
| Vericel Corporation | 1.27 Million USD | 28180.971% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2890.351% |
| Minerva Neurosciences, Inc. | 41 Million USD | 974.529% |
| Generation Bio Co. | 31.44 Million USD | 1240.276% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -104.486% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -1059.635% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 407.56% |
| Invivyd, Inc. | -198.47 Million USD | -80.674% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -297.246% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -14855.822% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -406.56% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -5154.125% |
| 2seventy bio, Inc. | 181.71 Million USD | 297.339% |
| ADMA Biologics, Inc. | 90.06 Million USD | 498.146% |
| Clene Inc. | 3.34 Million USD | 10836.347% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3848.098% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1567.026% |
| GeoVax Labs, Inc. | -6.45 Million USD | -5457.366% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -4.205% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1279.225% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 301.836% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -8664.222% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 7269.012% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -6784.124% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -175.198% |
| Evaxion Biotech A/S | 5.28 Million USD | 6882.761% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -218.558% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -173.167% |
| Trevena, Inc. | 2.25 Million USD | 15981.045% |
| Surrozen, Inc. | -32.66 Million USD | -997.826% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -596.164% |
| Cingulate Inc. | 3.08 Million USD | 11732.529% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -12109.534% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 5089.481% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3759.49% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -352.068% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -172.795% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -239.764% |
| Clearmind Medicine Inc. | -3.94 Million USD | -8995.283% |
| Kronos Bio, Inc. | -36.05 Million USD | -894.603% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3911.181% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 24692.782% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -560.93% |
| Statera Biopharma, Inc. | 14.41 Million USD | 2587.402% |
| ImmunityBio, Inc. | 618.22 Million USD | 158.004% |
| Korro Bio, Inc. | -132.94 Million USD | -169.735% |
| Kineta, Inc. | -4.54 Million USD | -7796.807% |
| BioVie Inc. | -17.73 Million USD | -1922.259% |
| Codexis, Inc. | -43.27 Million USD | -728.717% |
| Celularity Inc. | 65.19 Million USD | 650.075% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -11215.683% |
| Celcuity Inc. | 6.78 Million USD | 5386.261% |
| Virax Biolabs Group Limited | -3.36 Million USD | -10556.76% |
| Cibus, Inc. | -8.07 Million USD | -4339.143% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -8379.404% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 7946.696% |
| IN8bio, Inc. | -16.38 Million USD | -2088.016% |
| Kodiak Sciences Inc. | -103.87 Million USD | -245.217% |
| Annexon, Inc. | -193.75 Million USD | -85.076% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 996194.444% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1949.226% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -10107.629% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 134.013% |
| Eyenovia, Inc. | 1.25 Million USD | 28589.19% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1432.815% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -10957.478% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -978.576% |
| Arcellx, Inc. | -296.95 Million USD | -20.756% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1738.378% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -509.077% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1630.082% |
| Moolec Science SA | 117.61 Thousand USD | 304985.39% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -833.863% |
| Geron Corporation | 14.76 Million USD | 2529.334% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -845.709% |
| Royalty Pharma plc | 5.65 Billion USD | 106.338% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -153.565% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -5030.523% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -6586.62% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -154.808% |
| Humacyte, Inc. | -22.48 Million USD | -1494.743% |
| Structure Therapeutics Inc. | -124.33 Million USD | -188.4% |
| 89bio, Inc. | -289.05 Million USD | -24.058% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1320.624% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -20011.834% |
| Genelux Corporation | -6.89 Million USD | -5097.768% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -1054.557% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 528.945% |
| Notable Labs, Ltd. | -9.77 Million USD | -3568.106% |
| Liquidia Corporation | -80.17 Million USD | -347.259% |
| Mustang Bio, Inc. | -3.73 Million USD | -9498.34% |
| Immunovant, Inc. | -635.22 Million USD | 43.549% |
| Quantum-Si incorporated | -118.55 Million USD | -202.465% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1941.642% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -8555.419% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 4567.348% |
| Acasti Pharma Inc. | -23 Million USD | -1458.765% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -10549.528% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -2106.818% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -160.341% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -11406.815% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1512.963% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1831.143% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -111.837% |
| PepGen Inc. | -60.67 Million USD | -491.057% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1460.733% |
| United Therapeutics Corporation | -507.7 Million USD | 29.369% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1774.903% |
| Solid Biosciences Inc. | -47.75 Million USD | -650.982% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -41495.937% |
| Immuneering Corporation | -54.94 Million USD | -552.667% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -8430.868% |
| Silo Pharma, Inc. | -3.52 Million USD | -10074.877% |
| Belite Bio, Inc | -87.27 Million USD | -310.897% |
| XOMA Corporation | -29 Million USD | -1136.531% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -407.227% |
| Bionomics Limited | 227 Million USD | 257.964% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -208.383% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14056.889% |
| uniQure N.V. | -102.95 Million USD | -248.315% |
| Cassava Sciences, Inc. | -121.13 Million USD | -196.026% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -8508.815% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 975.666% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2898.027% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -11489.231% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 338396.226% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -10957.478% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 4126.884% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4735.41% |
| Altimmune, Inc. | -134.48 Million USD | -166.638% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 281.049% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -14056.889% |
| Compugen Ltd. | -12.9 Million USD | -2678.937% |
| Peak Bio, Inc. | 10.34 Million USD | 3567.974% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -126611.661% |
| Benitec Biopharma Inc. | -50.58 Million USD | -608.936% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -243.685% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1925.37% |
| Zura Bio Limited | -99.8 Million USD | -259.291% |
| PolyPid Ltd. | 6.17 Million USD | 5911.896% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 583.802% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1925.37% |
| Instil Bio, Inc. | 75.35 Million USD | 575.854% |
| argenx SE | -2.02 Billion USD | 82.325% |
| Immunome, Inc. | -97.02 Million USD | -269.574% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1494.105% |
| Verona Pharma plc | -220.44 Million USD | -62.67% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -399.831% |
| Shattuck Labs, Inc. | -121.42 Million USD | -195.324% |
| CervoMed Inc. | -7.79 Million USD | -4501.579% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -93.313% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -8100.183% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -172.198% |
| Moolec Science SA | 117.61 Thousand USD | 304985.39% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -15572.972% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2355.538% |
| AnaptysBio, Inc. | -18.15 Million USD | -1875.616% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1875.725% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -409.504% |
| NeurAxis, Inc. | 145.7 Thousand USD | 246218.051% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 3292.61% |
| Lumos Pharma, Inc. | -28.49 Million USD | -1158.534% |
| Achilles Therapeutics plc | -126.92 Million USD | -182.527% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -399.831% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -54586.228% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1626.182% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 24692.782% |
| Nutriband Inc. | -251.65 Thousand USD | -142393.155% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2622.603% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4719.812% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 205.408% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1610.824% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 19.862% |
| Palisade Bio, Inc. | -12.06 Million USD | -2872.677% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -155.571% |
| Beam Therapeutics Inc. | -262.72 Million USD | -36.492% |
| Neurogene Inc. | -131.95 Million USD | -171.755% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1743.72% |
| AEON Biopharma, Inc. | -4.88 Million USD | -7248.238% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 4.93% |
| Sesen Bio, Inc. | -112.55 Million USD | -218.6% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -259.097% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -15173.663% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -818.859% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -330.578% |
| Athira Pharma, Inc. | -88.99 Million USD | -302.919% |
| Vaccinex, Inc. | -1.28 Million USD | -27741.149% |
| HCW Biologics Inc. | 2.85 Million USD | 12652.841% |
| XOMA Corporation | -29 Million USD | -1136.531% |
| Nektar Therapeutics | 210.24 Million USD | 270.564% |
| Arvinas, Inc. | -313.8 Million USD | -14.275% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 22196.014% |
| Merus N.V. | -192.88 Million USD | -85.912% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 697.806% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -5068.55% |
| Rezolute, Inc. | -68.16 Million USD | -426.044% |
| Clene Inc. | 3.34 Million USD | 10836.347% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2619.299% |
| BeyondSpring Inc. | -13.75 Million USD | -2507.008% |
| Synlogic, Inc. | -6.68 Million USD | -5264.159% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 31722.046% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -4141.206% |
| Peak Bio, Inc. | 10.34 Million USD | 3567.974% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -335.081% |
| Krystal Biotech, Inc. | -350.23 Million USD | -2.387% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 388.897% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -112.191% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -11258.177% |
| MannKind Corporation | 143.89 Million USD | 349.198% |
| Ikena Oncology, Inc. | -109.15 Million USD | -228.515% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -4636.415% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -983.366% |
| Gossamer Bio, Inc. | 180.35 Million USD | 298.827% |
| CohBar, Inc. | -5.93 Million USD | -5946.371% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -1105.439% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 7953.57% |
| Legend Biotech Corporation | -949.39 Million USD | 62.229% |
| Mural Oncology plc | -255.84 Million USD | -40.162% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 1213.127% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -7512.423% |
| Disc Medicine, Inc. | -358.28 Million USD | -0.087% |
| Champions Oncology, Inc. | 4.81 Million USD | 7552.078% |
| REGENXBIO Inc. | 54.76 Million USD | 754.751% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -133252.423% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -137.442% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3879.07% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -344.448% |
| Vaxart, Inc. | -8.24 Million USD | -4251.341% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -614.616% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -181.99% |
| Cellectis S.A. | -43.85 Million USD | -717.681% |
| Longeveron Inc. | -2.9 Million USD | -12231.293% |
| Repare Therapeutics Inc. | -107.85 Million USD | -232.469% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 137.03% |
| Inozyme Pharma, Inc. | 12 Million USD | 3087.288% |
| Revolution Medicines, Inc. | -608.2 Million USD | 41.041% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -29053.984% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -35.259% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -138.948% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -2191.775% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -48358.649% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.251% |
| Denali Therapeutics Inc. | -74.86 Million USD | -378.988% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2890.351% |
| Veru Inc. | 4.77 Million USD | 7602.015% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -3088.636% |
| Cingulate Inc. | 3.08 Million USD | 11732.529% |
| Passage Bio, Inc. | 4.58 Million USD | 7921.025% |
| Context Therapeutics Inc. | -14.44 Million USD | -2381.649% |
| Exicure, Inc. | 5.84 Million USD | 6230.86% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -55.656% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -806.227% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2385.348% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -509.636% |
| Nuvalent, Inc. | -335.38 Million USD | -6.919% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 20776.095% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -381.451% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3933.678% |
| OmniAb, Inc. | 9.2 Million USD | 3996.49% |
| Anew Medical, Inc. | 1.43 Million USD | 25133.352% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 2288.984% |
| Lipocine Inc. | -4.75 Million USD | -7442.056% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -226.505% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2454.369% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -607.858% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1540.599% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -5235.426% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -444.752% |
| Ocugen, Inc. | -32.52 Million USD | -1002.654% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -319.041% |
| Q32 Bio Inc. | -37.94 Million USD | -844.962% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -57000.955% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2550.558% |
| Equillium, Inc. | -22.39 Million USD | -1501.438% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1302.511% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -999.079% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -144543.93% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 367.524% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 11313.071% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 109280.644% |
| Dominari Holdings Inc. | 195 Thousand USD | 183994.359% |
| Edesa Biotech, Inc. | -5.26 Million USD | -6708.432% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3921.465% |
| Bio-Techne Corporation | 267.74 Million USD | 233.93% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -2112.314% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -203.651% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -4167.452% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2734.511% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -46.294% |
| Nkarta, Inc. | 57.29 Million USD | 725.829% |
| BioCardia, Inc. | 212 Thousand USD | 169248.113% |
| Iterum Therapeutics plc | 13.43 Million USD | 2768.507% |